I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Gray Heppner Jr, D.
75
results:
Format
Online (75)
Mediatypes
Articles (Online) (72)
Bookchapter (Online) (1)
OpenAccess-fulltext (2)
Sorted by: Relevance
Sorted by: Year
?
1
Sequential Phase 1 and Phase 2 randomized, controlled trial..:
Kester, Kent E.
;
Gray Heppner Jr, D.
;
Moris, Philippe
...
Vaccine. 32 (2014) 49 - p. 6683-6691 , 2014
Link:
https://doi.org/10.1016/..
?
2
Phase 1 randomized double-blind safety and immunogenicity t..:
Stoute, José A.
;
Gombe, Joash
;
Withers, Mark R.
...
Vaccine. 25 (2007) 1 - p. 176-184 , 2007
Link:
https://doi.org/10.1016/..
?
3
Randomized Trial of 3-Dose Regimens of Tafenoquine (WR23860..:
Douglas S. Walsh
;
Polrat Wilairatana
;
Douglas B. Tang
...
Clinical Infectious Diseases. 39 (2004) 8 - p. 1095-1103 , 2004
Link:
https://www.jstor.org/st..
?
4
Results from tandem Phase 1 studies evaluating the safety, ..:
Otsyula, Nekoye
;
Angov, Evelina
;
Bergmann-Leitner, Elke
...
Malaria Journal. 12 (2013) 1 - p. , 2013
Link:
https://doi.org/10.1186/..
?
5
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with A..:
Cummings, James F.
;
Spring, Michele D.
;
Schwenk, Robert J.
...
Vaccine. 28 (2010) 31 - p. 5135-5144 , 2010
Link:
https://doi.org/10.1016/..
?
6
Expression of Genes Associated with Immunoproteasome Proces..:
Vahey, Maryanne T.
;
Wang, Zhining
;
Kester, Kent E.
...
The Journal of Infectious Diseases. 201 (2010) 4 - p. 580-589 , 2010
Link:
https://www.jstor.org/st..
?
7
Expression of Genes Associated with Immunoproteasome Proces..:
Vahey, Maryanne T.
;
Wang, Zhining
;
Kester, Kent E.
...
The Journal of Infectious Diseases. 201 (2010) 4 - p. 580-589 , 2010
Link:
https://doi.org/10.1086/..
?
8
Randomized, Double-Blind, Phase 2a Trial of Faltiparum Mala..:
Kester, Kent E.
;
Cummings, James F.
;
Ofori-Anyinam, Opokua
...
The Journal of Infectious Diseases. 200 (2009) 3 - p. 337-346 , 2009
Link:
https://www.jstor.org/st..
?
9
Cell-mediated immunity elicited by the blood stage malaria ..:
Lyke, Kirsten E.
;
Daou, Modibo
;
Diarra, Issa
...
Vaccine. 27 (2009) 15 - p. 2171-2176 , 2009
Link:
https://doi.org/10.1016/..
?
10
Randomized, Double‐Blind, Phase 2a Trial of Falciparum Mala..:
Kester, Kent E.
;
Cummings, James F.
;
Ofori‐Anyinam, Opokua
...
The Journal of Infectious Diseases. 200 (2009) 3 - p. 337-346 , 2009
Link:
https://doi.org/10.1086/..
?
11
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day im..:
Kester, Kent E.
;
Cummings, James F.
;
Ockenhouse, Christian F.
...
Vaccine. 26 (2008) 18 - p. 2191-2202 , 2008
Link:
https://doi.org/10.1016/..
?
12
Improved T cell responses to Plasmodium falciparum circumsp..:
Mettens, Pascal
;
Dubois, Patrice M.
;
Demoitié, Marie-Ange
...
Vaccine. 26 (2008) 8 - p. 1072-1082 , 2008
Link:
https://doi.org/10.1016/..
?
13
Phase I dose escalation safety and immunogenicity trial of ..:
Polhemus, Mark E.
;
Magill, Alan J.
;
Cummings, James F.
...
Vaccine. 25 (2007) 21 - p. 4203-4212 , 2007
Link:
https://doi.org/10.1016/..
?
14
A phase I/IIa safety, immunogenicity, and efficacy bridging..:
Kester, Kent E.
;
McKinney, Denise A.
;
Tornieporth, Nadia
...
Vaccine. 25 (2007) 29 - p. 5359-5366 , 2007
Link:
https://doi.org/10.1016/..
?
15
Hb G‐Philadelphia or Stanleyville II? When the phenotype an..:
Waitumbi, John N.
;
Kifude, Carolyne M.
;
Withers, Mark R.
...
European Journal of Haematology. 79 (2007) 2 - p. 177-178 , 2007
Link:
https://doi.org/10.1111/..
1-15